Metis Global Partners’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$239K	Sell	403 -48	-11%	-$23.9K	0.01%	672
2025 Q4	$220K	Sell	451 -43	-9%	-$20K	0.01%	713
2025 Q3	$207K	Buy	+494	New	+$166K	﹤0.01%	728
2025 Q2	–	Sell	-1,600	Closed	-$493K	–	812
2025 Q1	$493K	Buy	1,600 +170	+12%	+$58.3K	0.01%	593
2024 Q4	$505K	Sell	1,430 -74	-5%	-$27.2K	0.02%	585
2024 Q3	$539K	Sell	1,504 -95	-6%	-$32.1K	0.02%	558
2024 Q2	$509K	Sell	1,599 -57	-3%	-$15.1K	0.02%	539
2024 Q1	$380K	Sell	1,656 -27	-2%	-$6.09K	0.01%	611
2023 Q4	$370K	Sell	1,683 -131	-7%	-$30.2K	0.01%	609
2023 Q3	$410K	Buy	1,814 +103	+6%	+$23.7K	0.02%	574
2023 Q2	$378K	Sell	1,711 -65	-4%	-$14.4K	0.02%	580
2023 Q1	$398K	Sell	1,776 -765	-30%	-$189K	0.03%	534
2022 Q4	$707K	Sell	2,541 -433	-15%	-$109K	0.06%	345
2022 Q3	$623K	Sell	2,974 -121	-4%	-$27.1K	0.1%	229
2022 Q2	$730K	Buy	+3,095	New	+$629K	0.12%	202